RAREVSSNDL• 28 Days (Normalized)
RARE vs SNDL (Ultragenyx Pharmaceutical Inc. vs SNDL Inc.)
Showing Closing Date Range from Aug, 19 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
RARE Performance $12.95
-50.65%
Ultragenyx Pharmaceutical Inc.
Normalized Baseline0.00%
SNDL Performance $1.37
+4.2%
SNDL Inc.
Normalized Baseline0.00%
Alpha Spread Margin SNDL LEADS
-54.85%
SNDL outperforming by 54.85%
RARESNDL
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
RARE SNDL
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | RARE Price | RARE Gain (%) | SNDL Price | SNDL Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $12.95 | -50.65% | $1.37 | +4.20% | -54.85% |
| Sep 15, 2026 | $13.07 | -50.19% | $1.35 | +3.05% | -53.24% |
| Sep 14, 2026 | $13.61 | -48.13% | $1.37 | +4.58% | -52.71% |
| Sep 11, 2026 | $14.30 | -45.50% | $1.34 | +2.29% | -47.79% |
| Sep 10, 2026 | $14.40 | -45.12% | $1.34 | +2.29% | -47.41% |
| Sep 09, 2026 | $14.31 | -45.46% | $1.40 | +6.87% | -52.33% |
| Sep 08, 2026 | $14.88 | -43.29% | $1.44 | +9.92% | -53.21% |
| Sep 04, 2026 | $15.30 | -41.69% | $1.44 | +9.54% | -51.23% |
| Sep 03, 2026 | $14.85 | -43.41% | $1.41 | +7.63% | -51.04% |
| Sep 02, 2026 | $26.53 | +1.11% | $1.42 | +8.40% | -7.29% |
| Sep 01, 2026 | $25.81 | -1.64% | $1.36 | +3.82% | -5.46% |
| Aug 31, 2026 | $25.21 | -3.93% | $1.37 | +4.58% | -8.51% |
| Aug 28, 2026 | $25.61 | -2.40% | $1.36 | +3.44% | -5.84% |
| Aug 27, 2026 | $26.26 | +0.08% | $1.35 | +3.05% | -2.97% |
| Aug 26, 2026 | $26.44 | +0.76% | $1.38 | +5.34% | -4.58% |
Page 1 of 2